Alan Ezekowitz
InvestorVenture Partner at Third Rock Ventures · Board director at Fulcrum Therapeutics
Princeton, New Jersey
Writes $100K – $5M checks · typically $1.5M
Find your path to Alan
248 people in our graph share verified history with Alan — schools, employers, funds. One of them is your warm intro.
Lisa PurcellunlockedAlan: together at Third Rock Ventures (2024–2026)
×10Alan: together at Third Rock Ventures
Alan: together at Merck Sharp & Dohme
About
A physician scientist who spent over 20 years at Harvard Medical School, heading the Laboratory of Developmental Immunology and MassGeneral Hospital for Children. He later led a franchise at Merck and co-founded Abide Therapeutics, acquired by Lundbeck in 2019.
Invests in
BiotechDeep TechHealthtech
Board director at Fulcrum Therapeutics
Intro paths
→
In turn, Alan can intro founders to Fulcrum Therapeutics's investors below.
Fulcrum Therapeutics's investors · 2
Experience
- Third Rock VenturesAdvisory Partnercurrent2023 — presentBoston MA USA
- Third Rock VenturesVenture Partner2019 — 2023Greater Boston
- Abide TherapeuticsPresident and CEO2011 — 2019
- Vividion Therapeutics. Inc.Senior Consultant2015 — 2016San Diego Metropolitan Area
- Alan Ezekowitz LLCPrincipal2011
- Merck Sharp & DohmeSVP and Franchise Head2006 — 2011
- Mass General HospitalChief MassGeneral Hospital for Children1999 — 2006Boston, Massachusetts, United States
- Chief, MassGeneral Hospital for Children and Head fo Laboratory for Developmental Immunology at MGH,Charles Wilder Professor of Pediatrics Harvard Medical School1995 — 2005Boston, Massachusetts, United States
Skills & more
Business DevelopmentPain Management6Allergy6Pharmaceutical Industry14Endocrinology20Dermatology7Biotechnology3Drug Discovery2Immunology36Clinical Development5Drug Development8Strategy12
+8 more
Clinical TrialsOncologyCross-functional Team LeadershipAsthmaInfectious DiseasesVaccinesBiopharmaceuticalsStrategic PlanningFrom Alan's professional profile.
Investments
Led
Abide Therapeutics
Per the firm's website.
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alexis Borisy
General Partner at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures
Ava Brunelle
Investor at Third Rock Ventures
Network10
Abbie Celniker
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Barbara Weber
Venture Partner at Third Rock Ventures
Beryl Cummings
Senior Associate at Third Rock Ventures
Cary Pfeffer
Investor at Third Rock Ventures
Charles Homcy
Investor at Third Rock Ventures
Christoph Lengauer
CSO at Curie.Bio
Craig Muir
Investor at Third Rock Ventures
David Kaufman
Investor at Third Rock Ventures
Investors connected to Alan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Alan Ezekowitz?
- A physician scientist who spent over 20 years at Harvard Medical School, heading the Laboratory of Developmental Immunology and MassGeneral Hospital for Children. He later led a franchise at Merck and co-founded Abide Therapeutics, acquired by Lundbeck in 2019.
- Where does Alan Ezekowitz work?
- Alan Ezekowitz is Venture Partner at Third Rock Ventures and Board director at Fulcrum Therapeutics.
- What does Alan Ezekowitz invest in?
- Alan Ezekowitz invests in Biotech, Deep Tech, Healthtech.
- What check size does Alan Ezekowitz write?
- Alan Ezekowitz typically writes checks of $100K – $5M.
- What companies has Alan Ezekowitz invested in?
- Investments tracked here include Abide Therapeutics.
- Where did Alan Ezekowitz go to school?
- Alan Ezekowitz studied at University of Oxford (DPhil, Cell/Cellular and Molecular Biology); University of Cape Town (Medicine).
- Does Alan Ezekowitz lead rounds?
- Yes — Alan Ezekowitz has led 1 tracked investment.
Same school
Also attended University of Oxford1,552
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 1,546 more
Also attended University of Cape Town268
Roelof BothaAdvisor & former Steward at Sequoia Capital; SpaceX board memberJames DetweilerVP of Investments at Felicis VenturesAvron MarcusInvestor at Index VenturesLaurel BowdenPartner at 83NorthAndy VitusPartner at Scale Venture PartnersErik van VlaanderenGeneral Partner at 4Di Capital
+ 262 more
Shared employers
Also worked at Third Rock Ventures88
Lisa PurcellInvestor at Third Rock VenturesPaul MeloneInvestor at Third Rock VenturesLee VeneziaInvestor at Third Rock VenturesKevin MunnellyInvestor at Third Rock VenturesAmanda ChanInvestor at Third Rock VenturesJigar RaythathaInvestor at Third Rock Ventures
+ 82 more
Also worked at Vividion Therapeutics. Inc.3
Also worked at Merck Sharp & Dohme153
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesUri LopatinInvestor at Khosla VenturesMichele WashkoPresident & CEO at Life Sciences Greenhouse Investments
+ 147 more
